Your browser does not fully support modern features. Please upgrade for a smoother experience.
Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic. For video creation, please contact our Academic Video Service.
Version Summary Created by Modification Content Size Created at Operation
1 Vicky Zhou + 836 word(s) 836 2020-12-15 07:49:15

Video Upload Options

We provide professional Academic Video Service to translate complex research into visually appealing presentations. Would you like to try it?
No, upload directly Yes
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Zhou, V. CTNNB1 Gene. Encyclopedia. Available online: https://encyclopedia.pub/entry/5301 (accessed on 25 September 2026).
Zhou V. CTNNB1 Gene. Encyclopedia. Available at: https://encyclopedia.pub/entry/5301. Accessed September 25, 2026.
Zhou, Vicky. "CTNNB1 Gene" Encyclopedia, https://encyclopedia.pub/entry/5301 (accessed September 25, 2026).
Zhou, V. (2020, December 24). CTNNB1 Gene. In Encyclopedia. https://encyclopedia.pub/entry/5301
Zhou, Vicky. "CTNNB1 Gene." Encyclopedia. Web. 24 December, 2020.
CTNNB1 Gene
Edit
This entry is adapted from the peer-reviewed paper https://medlineplus.gov/genetics/gene/ctnnb1

catenin beta 1

genes

References

  1. Al-Hussain T, Ali A, Akhtar M. Wilms tumor: an update. Adv Anat Pathol. 2014May;21(3):166-73. doi: 10.1097/PAP.0000000000000017. Review.
  2. Barker N. The canonical Wnt/beta-catenin signalling pathway. Methods Mol Biol.2008;468:5-15. doi: 10.1007/978-1-59745-249-6_1. Review.
  3. Chan EF, Gat U, McNiff JM, Fuchs E. A common human skin tumour is caused byactivating mutations in beta-catenin. Nat Genet. 1999 Apr;21(4):410-3.
  4. Deng C, Dai R, Li X, Liu F. Genetic variation frequencies in Wilms' tumor: Ameta-analysis and systematic review. Cancer Sci. 2016 May;107(5):690-9. doi:10.1111/cas.12910.
  5. Ferenc T, Wroński JW, Kopczyński J, Kulig A, Sidor M, Stalińska L, Dziki A,Sygut J. Analysis of APC, alpha-, beta-catenins, and N-cadherin proteinexpression in aggressive fibromatosis (desmoid tumor). Pathol Res Pract.2009;205(5):311-24. doi: 10.1016/j.prp.2008.11.002.
  6. Fu Y, Zheng S, An N, Athanasopoulos T, Popplewell L, Liang A, Li K, Hu C, Zhu Y. β-catenin as a potential key target for tumor suppression. Int J Cancer. 2011 Oct 1;129(7):1541-51. doi: 10.1002/ijc.26102.
  7. Huss S, Nehles J, Binot E, Wardelmann E, Mittler J, Kleine MA, Künstlinger H, Hartmann W, Hohenberger P, Merkelbach-Bruse S, Buettner R, Schildhaus HU.β-catenin (CTNNB1) mutations and clinicopathological features of mesentericdesmoid-type fibromatosis. Histopathology. 2013 Jan;62(2):294-304. doi:10.1111/j.1365-2559.2012.04355.x.
  8. Kajino Y, Yamaguchi A, Hashimoto N, Matsuura A, Sato N, Kikuchi K.beta-Catenin gene mutation in human hair follicle-related tumors. Pathol Int.2001 Jul;51(7):543-8.
  9. Kotiligam D, Lazar AJ, Pollock RE, Lev D. Desmoid tumor: a disease opportunefor molecular insights. Histol Histopathol. 2008 Jan;23(1):117-26. doi:10.14670/HH-23.117. Review.
  10. Lazar AJ, Calonje E, Grayson W, Dei Tos AP, Mihm MC Jr, Redston M, McKee PH.Pilomatrix carcinomas contain mutations in CTNNB1, the gene encodingbeta-catenin. J Cutan Pathol. 2005 Feb;32(2):148-57.
  11. Lips DJ, Barker N, Clevers H, Hennipman A. The role of APC and beta-catenin inthe aetiology of aggressive fibromatosis (desmoid tumors). Eur J Surg Oncol. 2009Jan;35(1):3-10. doi: 10.1016/j.ejso.2008.07.003.
  12. MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components,mechanisms, and diseases. Dev Cell. 2009 Jul;17(1):9-26. doi:10.1016/j.devcel.2009.06.016. Review.
  13. Moreno-Bueno G, Gamallo C, Pérez-Gallego L, Contreras F, Palacios J.beta-catenin expression in pilomatrixomas. Relationship with beta-catenin genemutations and comparison with beta-catenin expression in normal hair follicles.Br J Dermatol. 2001 Oct;145(4):576-81.
  14. Tejpar S, Nollet F, Li C, Wunder JS, Michils G, dal Cin P, Van Cutsem E, BapatB, van Roy F, Cassiman JJ, Alman BA. Predominance of beta-catenin mutations andbeta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor).Oncogene. 1999 Nov 11;18(47):6615-20.
  15. Xia J, Urabe K, Moroi Y, Koga T, Duan H, Li Y, Furue M. beta-Catenin mutation and its nuclear localization are confirmed to be frequent causes of Wnt signalingpathway activation in pilomatricomas. J Dermatol Sci. 2006 Jan;41(1):67-75.
More
©Text is available under the terms and conditions of the Creative Commons-Attribution ShareAlike (CC BY-SA) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Genetics & Heredity
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register : Vicky Zhou
View Times: 1.2K
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 24 Dec 2020
Table of Contents
    Notice
    You are not a member of the advisory board for this topic. If you want to update advisory board member profile, please contact office@encyclopedia.pub.
    OK
    Confirm
    Only members of the Encyclopedia advisory board for this topic are allowed to note entries. Would you like to become an advisory board member of the Encyclopedia?
    Yes
    No
    ${ textCharacter }/${ maxCharacter }
    Submit
    Cancel
    There is no comment~
    ${ textCharacter }/${ maxCharacter }
    Submit
    Cancel
    ${ selectedItem.replyTextCharacter }/${ selectedItem.replyMaxCharacter }
    Submit
    Cancel
    Confirm
    Are you sure to Delete?
    Yes No
    Academic Video Service
    Feedback